<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Acuitas, CureVac settle lawsuit over COVID-19-vaccine | DNBC News</title>
    <link rel="stylesheet" href="styles.css">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@5.3.3/dist/css/bootstrap.min.css">
    <link rel="icon" type="image/x-icon" href="image (1).png">
    <style>
        .heading {
            line-height: 60px;
            width: 700px;
            cursor: pointer;
            margin-top: 30px;
        }

        .heading:hover {
            text-decoration: underline;
            text-underline-offset: 10px;
        }

        .img3 {
            margin-top: 20px;
            border-radius: 10px;
        }

        .container-3 {
            display: flex;
        }

        .img4 {
            border-radius: 100%;
            width: 50px;
            height: 50px;
            display: block;
            margin-top: 20px;
        }

        .publisher {
            margin-top: 30px;
            margin-left: 20px;
            font-size: large;
        }

        .article {
            line-height: 30px;
            width: 700px;
            font-size: 20px;
            margin-top: 30px;
        }

        .main-6 {
            margin-left: 25%;
        }

        .carosuel1 {
            margin: 150px 400px auto;
            width: 700px;
        }

        .facebook1 {
            width: 170px;
            height: 50px;
            background-color: rgb(24, 119, 242);
            color: white;
            border: none;
            font-size: large;
            margin-top: 30px;
            border-radius: 5px;
        }

        .facebook1:hover {
            background-color: rgb(7, 49, 104);
            transition-duration: 1s;
        }

        .instagram1 {
            background-color: #ee2a7b;
            width: 170px;
            height: 50px;
            color: white;
            border: none;
            font-size: large;
            margin-top: 30px;
            border-radius: 5px;
        }

        .instagram1:hover {
            background-color: #7a0b39;
            transition-duration: 1s;
        }

        .twitter1 {
            background-color: rgb(29, 161, 242);
            width: 170px;
            height: 50px;
            color: white;
            border: none;
            font-size: large;
            margin-top: 30px;
            border-radius: 5px;
        }

        .twitter1:hover {
            background-color: rgb(12, 84, 129);
            transition-duration: 1s;
        }

        .youtube1 {
            background-color: rgb(255, 0, 0);
            width: 170px;
            height: 50px;
            color: white;
            border: none;
            font-size: large;
            margin-top: 30px;
            border-radius: 5px;
        }

        .youtube1:hover {
            background-color: rgb(82, 9, 9);
            transition-duration: 1s;
        }

        .advertisment {
            color: gray;
            text-align: center;
            margin-bottom: 15px;
        }

        .midimg {
            width: 700px;
        }

        .homepage {
            color: black;
            text-decoration: none;
        }
    </style>
</head>

<body>
    <div class="header">
        <span style="  margin-left:50px; font-size: large;">&#x1F319 27.9<sup style="margin-left:5px">C</sup> Karachi
        </span>
        <span style="margin-left:30px; font-size: large;">Thursday, May 23, 2024</span>
    </div>
    <div class="main">
        <nav class="nav">
            <img class="logo" src="image (1).png" width="200px" height="90px" alt="DBNC News">
            <a class="anchor" href="DNBC.html"> <span class="home">Home</span></a>
            <span class="dropdown">
                <span>Cities</span>
                <span class="dropdown-content">
                    <a class="anchor" href="New York.html">New York</a>
                    <a class="anchor" href="Los Angeles.html">Los Angeles</a>
                    <a class="anchor" href="Houston.html">Houston</a>
                    <a class="anchor" href="Paris.html">Paris</a>
                    <a class="anchor" href="Toronto.html">Toronto</a>
                </span>
            </span>
            <a class="anchor" href="Health.html"><span class="health">Health</span></a>
            <a class="anchor" href="Business.html"><span class="business1">Business</span></a>
            <a class="anchor" href="Sports.Html"><span class="sports">Sports</span></a>
            <a class="anchor" href="Today In World.html"><span class="top10news">Today In World</span></a>
            <a class="anchor" href="about-us.html"><span class="aboutus">About Us</span></a>
            <a class="anchor" href="contact-us.html"><span class="contactus">Contact Us</span></a>
        </nav>
    </div>
    <div class="carosuel1">
        <h6 class="advertisment">Advertisement</h6>
        <div id="carouselExampleControlsNoTouching" data-bs-ride="carousel" data-bs-interval="2500"
            class="carousel slide">
            <div class="carousel-inner">
                <div class="carousel-item active">
                    <a href="https://www.foodpanda.pk/" target="_blank"><img height="120px"
                            src="https://i0.wp.com/www.adobomagazine.com/wp-content/uploads/2020/09/Weather-Trigger-Foodpanda-Campaign-2020-Hero.jpg?fit=1440%2C757&ssl=1"
                            class="d-block w-100" alt="Foodpanda"></a>
                </div>
                <div class="carousel-item">
                    <a href="https://www.daraz.pk/" target="_blank"><img height="120px"
                            src="https://blog.daraz.pk/wp-content/uploads/2021/12/HOW-TO-COLLECT-COINS.jpg"
                            class="d-block w-100" alt="Daraz"></a>
                </div>
                <div class="carousel-item">
                    <a href="https://www.kravemart.com/" target="_blank"><img height="120px"
                            src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcQMnKzA_2VQy2nLDLRKa_I-Lk5z04N5iucVS2kqGakKhA&s"
                            class="d-block w-100" alt="krave mart"></a>
                </div>
            </div>
            <button class="carousel-control-prev" type="button" data-bs-target="#carouselExampleControlsNoTouching"
                data-bs-slide="prev">
                <span class="carousel-control-prev-icon" aria-hidden="true"></span>
                <span class="visually-hidden">Previous</span>
            </button>
            <button class="carousel-control-next" type="button" data-bs-target="#carouselExampleControlsNoTouching"
                data-bs-slide="next">
                <span class="carousel-control-next-icon" aria-hidden="true"></span>
                <span class="visually-hidden">Next</span>
            </button>
        </div>
    </div>
    <div class="main-6">
        <h1 class="heading">Acuitas, CureVac settle lawsuit over COVID-19-vaccine | DNBC News</h1>
        <img class="img3" src="https://arynews.tv/wp-content/uploads/2020/07/Cure-Vac.jpg" width="700px" height="400px"
            alt="Acuitas, CureVac settle lawsuit over COVID-19-vaccine | DNBC News">
        <div class="container-3">
            <img class="img4" src="image (1).png" alt="DNBC News">
            <p class="publisher"><span style="color:gray">By</span> <a class="homepage" href="DNBC.html">DNBC News</a> |
                <span style="color:gray">16 May 2024</span>
            </p>
        </div>
        <div class="article">
            <p>The resolution of the lawsuit between Acuitas Therapeutics and CureVac regarding their COVID-19 vaccine
                marks a significant development in the global effort to combat the pandemic. The settlement brings an
                end to legal disputes that have been ongoing amid the urgent need for effective vaccines to address the
                public health crisis.​</p>
            <p>Both Acuitas Therapeutics and CureVac have been pivotal players in the development of mRNA-based COVID-19
                vaccines. Acuitas specializes in lipid nanoparticle (LNP) delivery systems, crucial for the
                effectiveness of mRNA vaccines, while CureVac has been at the forefront of mRNA vaccine development. The
                settlement signals a renewed commitment to collaboration and cooperation between these key stakeholders
                in the fight against COVID-19.</p>
            <p>The resolution of the lawsuit is expected to facilitate the continued development and production of
                COVID-19 vaccines, potentially accelerating their availability to populations worldwide. As the global
                vaccination effort remains a top priority in controlling the spread of the virus and preventing further
                outbreaks, resolving legal disputes between key industry players is essential for ensuring uninterrupted
                access to vaccines for those who need them most.</p>
            <p>The settlement reflects the collective commitment of the scientific community, pharmaceutical companies,
                and regulatory bodies to overcome challenges and advance vaccine development efforts. It underscores the
                importance of innovation, collaboration, and agility in responding to public health emergencies, such as
                the COVID-19 pandemic.</p>
            <img class="midimg" style="border-radius: 10px;"
                src="https://cloudfront-us-east-2.images.arcpublishing.com/reuters/3E3LKROSWBK3PGYCN6U3R7KIKA.jpg"
                alt="Acuitas, CureVac settle lawsuit over COVID-19-vaccine | DNBC News">
            <p style="margin-top:10px">While the settlement represents a positive step forward, it's essential to remain
                vigilant and proactive in addressing the evolving nature of the pandemic. Continued research,
                surveillance, and vaccination efforts are necessary to stay ahead of emerging variants of the virus and
                to ensure that vaccines remain effective against new strains.</p>
            <p>
                As the world continues to navigate the challenges posed by COVID-19, the resolution of the lawsuit
                between Acuitas Therapeutics and CureVac offers a glimpse of hope and progress. It reinforces the
                importance of solidarity and cooperation in addressing complex global health crises and underscores the
                resilience of the scientific community in overcoming obstacles. Moving forward, stakeholders must build
                on this momentum, leveraging collective expertise and resources to accelerate the development and
                distribution of vaccines while ensuring equitable access for all. By working together towards common
                goals, we can emerge stronger and more prepared to confront future challenges on a global scale.</p>
            <p>The resolution of the lawsuit between Acuitas Therapeutics and CureVac over their COVID-19 vaccine
                represents a milestone in the collective response to the pandemic. By resolving legal disputes and
                fostering collaboration, stakeholders can focus on advancing vaccine development, production, and
                distribution efforts, ultimately saving lives and bringing an end to the global health crisis.</p>
        </div>
        <a href="https://www.facebook.com/profile.php?id=61559414450309" target="_blank"><button
                class="facebook1">Facebook</button></a>
        <a href="https://www.instagram.com/dnbc_news234/" target="_blank"><button
                class="instagram1">Instagram</button></a>
        <button class="twitter1">Twitter</button>
        <a href="https://www.youtube.com/@DNBCNews" target="_blank"><button class="youtube1">Youtube</button></a>
    </div>
    <div class="footer">
        <h2 class="followus">Follow Us</h2>
        <div class="socialmediaaccounts">
            <h1 class="channelname">DNBC News</h1>
            <img class="twitter" src="1657046580twitter-logo-png-white.png" alt="Twitter">
            <a href="https://www.instagram.com/dnbc_news234/" target="_blank"><img class="instagram"
                    src="1683193139instagram-icon-png-white.png" alt="Instagram"></a>
            <a href="https://www.facebook.com/profile.php?id=61559414450309" target="_blank"><img class="facebook"
                    src="1692798894facebook-transparent-logo-white.png" alt="facebook"></a>
            <a href="https://www.youtube.com/@DNBCNews" target="_blank"><img class="youtube"
                    src="1656503919white-youtube-logo.png" alt="Youtube"></a>
        </div>
        <div class="main-5">
            <div>
                <h1 class="aboutus1">Abouts Us</h1>
                <p class="info">DNBC NEWS brings you 24/7 Live Streaming, Headlines, Bulletins, Talk Shows,
                    Infotainment, and much more. Watch minute-by-minute updates of current affairs and happenings from
                    Pakistan and all around the world!</p>
            </div>
            <div>
                <h1 class="corporate">Corporate</h1>
                <a class="anchor" href="contact-us.html" target="_blank">
                    <p class="contact-us">Contact us</p>
                </a>
                <a class="anchor" href="about-us.html" target="_blank">
                    <p class="about-us">About us</p>
                </a>
                <a class="anchor" href="feedback.html" target="_blank">
                    <p class="feedback">Feedback</p>
                </a>
                <a class="anchor" href="terms&condition.html" target="_blank">
                    <p class="termsconditions">Terms & Conditions</p>
                </a>
            </div>
            <div>
                <h1 class="getintouch">Get in Touch</h1>
                <img class="phone" src="360_F_445165216_BP1VjN2nqOJoRAZJi3lYk601jWTbgyo4.jpg" alt="phone" height="35px"
                    widt="70px;">
                <p class="number">(+92)-312-8432035</p>
                <br>
                <img class="location" src="https://cdn-icons-png.flaticon.com/256/169/169473.png" alt="location"
                    height="35px" widt="70px;">
                <p class="address">#50, Barkat Market New Garden Town, Karachi</p>
                <br>
                <img class="email" src="360_F_530944081_r10lXWYlmGPcWk2mKe8oAoTEVZCAMAkd.jpg" alt="email" height="25px"
                    widt="50px;">
                <P Class="mail">support@dnbc.com</P>
            </div>
        </div>
        <div>
            <hr style="color:white;">
            <p class="end">© 2024 DNBC News. All Rights Reserved.</p>
        </div>
    </div>
    <script src="https://cdn.jsdelivr.net/npm/bootstrap@5.3.3/dist/js/bootstrap.bundle.min.js"></script>
</body>

</html>